More on the Tax-Cuts-and-Medicaid-Cuts Bill, Including an Apex Analysis of a Biotech-Boosting R&D Tax Provision
Plus two academic papers worth reading, one raising concerns about step therapy and one raising concerns about MFN. Lots to be concerned about today!
Jul 8, 2025
